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Abstract
Unprotected sex, common among people who inject drugs, puts them and their partners at risk of sexually transmitted
infections including human immunodeficiency virus (HIV). This analysis assesses the changes in sexual risk behavior with
regular female partners (RFPs), among married men who inject drugs, before and after implementation of a HIV
prevention intervention, and identifies correlates of unprotected sex. People who inject drugs (PWID) were assessed
at three points: baseline, preintervention follow-up visit (FV)1, and postintervention FV2. Descriptive analysis was used
for reporting changes in sexual behavior over time. Generalized estimating equation assessed the population-averaged
change in self-reported unprotected sex with an RFP, attributable to intervention uptake. Multivariable logistic regression determined correlates of self-reported unprotected sex with an RFP at FV2. Findings suggest that the proportion of
men reporting any unprotected sex remained high (baseline ¼ 46.0%, FV1 ¼ 43.5%, FV2 ¼ 37.0%). A reduction was
observed in unprotected sex after the intervention phase, but this could not be attributed to uptake of the intervention.
Higher odds of self-reported unprotected sex with an RFP in the past three months at FV2 were associated with selfreported unprotected sex at baseline, living with family, and being HIV-negative. Married male PWID should receive
counseling for safe sex with RFPs, especially those who are HIV-negative and live with their families.
Keywords
HIV, Indian subcontinent, sexual behavior, high-risk behavior, men
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Background
People who inject drugs (PWID) constitute a high-risk
population at risk of contracting and transmitting
human immunodeficiency virus (HIV) and other infectious diseases.1 Globally, HIV prevalence among PWID
is 28 times higher than among the rest of the adult population.2 In India, there are an estimated 177,000
PWID3 with an HIV prevalence of 6.3%.4 While sharing
of injection paraphernalia is a key risk factor for HIV
among them,5 it can be significantly reduced with
increased availability of sterile injecting equipment and
prevention interventions. However, unsafe sexual behaviors among PWID have been difficult to change.6
Multiple studies have also shown relatively high prevalence of non-HIV sexually transmitted infections (STIs)
among PWID, suggesting risky sexual behaviors.

Uusküla et al.7 in their study in Estonia reported more
than a fifth of PWID to be positive for hepatitis B surface antigen, while in India, Saraswati et al.8 reported
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9.2% hepatitis B positivity. Ghosh et al.9 highlighted
high prevalence of other STIs such as human papillomavirus and coexisting STIs such as herpes simplex virus
(type 2) and syphilis among them. Moderate prevalence
of syphilis sero-positivity has also been reported among
PWID in Estonia – 2.9%,7 China – 5.4%,10 Russia – 8–
20%,11 and India – 12.9%.12
Globally, it has been documented that sexually-active
male PWID often have non-injecting sex partners.13–16
The onward transmission of HIV and non-HIV STIs to
female sex partners is facilitated by high rates of unprotected sex among PWID,14,17 especially with exclusive
main partners.15,18 Niccolai et al.19 reported high prevalence of unprotected intercourse at last sex (60%) and
high HIV prevalence (15%) among non-drug-using sex
partners of PWID. Similar high HIV prevalence among
female partners has been reported in Kazakhstan
(10.4%) and Vietnam (11.5%).20–22 In India, as per
the National Integrated Biological and Behavioral
Surveillance (IBBS), more than 40% of male PWID
reported being married. Studies from Chennai and
Manipur reported 5 and 45% HIV-positivity among
female sex partners of male PWID, respectively.23,24
Thus, spouses of men who inject drugs represent a
group of married monogamous women who are at
higher risk for HIV and other infections due to their
husband’s risk behaviors.25
A few studies in the United States and Russia have
explored correlates of unsafe sex among PWID. Unsafe
injection practices, low self-efficacy for sexual risk
reduction, and frequent interaction with the sex partner
were independent predictors of inconsistent condom
use.6,26,27 Further, sexual behavior in intimate partnerships such as marriage is influenced by additional factors such as intention to conceive, mutual trust, and
desire for intimacy.28,29 Therefore, determinants of
unprotected sex with regular female partners (RFPs)
are more complex, but have largely remained unexplored for this high-risk population group.
In India, evidence indicates an increase in HIV prevalence in PWID in newer geographies such as Delhi
which has an estimated population of 17,000 PWID30
with HIV prevalence of 16.2%.4 This analysis aims to
describe the sexual behavior of PWID with their RFP
before and after the introduction of select HIV prevention and care interventions – facility-based HIV counseling and testing, HIV prevention counseling by outreach
workers (ORWs), and needle syringe programs – in
Delhi. Correlates of unprotected sexual behavior with
RFPs in the post-intervention phase are also assessed.

Methods
The Population Council initiated a prospective cohort
study at five drop-in centers in Delhi, to examine HIV
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incidence and behavior change among PWID before
and after provision of internationally recommended
HIV prevention interventions.31 Before the study initiation, ORWs undertook a mapping exercise to identify
hotspots and estimate the number of PWID who could
be contacted at each hotspot. Study sites, were thus setup near hotspots with high estimates of PWID in central, east, north-east, and north-west districts of Delhi.
Study methods have been described elsewhere,32 but
briefly, participants were recruited through peer referral, targeted outreach by ORWs, and self-referrals. The
study entailed three rounds of data collection: baseline, a
preintervention follow-up visit after six months (FV1),
and a postintervention follow-up visit (FV2) 12 months
after FV1. At baseline, participants were tested for HIV,
followed by repeat HIV testing at FV1 and FV2, if they
were HIV-negative at the previous study visit. No HIV
prevention interventions were provided during the
observational control phase (baseline to FV1).
However, PWID could still receive abscess care, outpatient medical consultations for common conditions,
bathing facilities, and midday meals at drop-in centers,
all of which continued through the intervention phase
(FV1 to FV2).

Intervention
Returning participants who completed FV1 data collection received the internationally recommended HIV prevention and care intervention through the project.31
These interventions included individual/group counseling sessions, needle syringe program, condoms, hepatitis
B and C testing, counseling for STI prevention, STI
screening, and symptomatic treatment. Referrals were
also provided for opioid substitution therapy, deaddiction, and detoxification services. Access to projectrelated interventions ended after participants completed
their last round of data collection (FV2). Throughout
the study period, participants were free to access services
available at government healthcare facilities or other
community-based drop-in centers.

Study participants and procedures
To be eligible for study participation, participants had
to be at least 18 years of age, must have injected drugs
at least once in the last three months, and lived in Delhi
at the time of study enrollment. For this analysis, male
participants who reported being married or cohabiting
(had an RFP – spouse or live-in partner) and returned
for their postintervention FV2 were included. The
study questionnaire was pilot tested for clarity of language, comprehension, content, and cultural sensitivity
and was administered in Hindi. Face-to-face interviews
were conducted by trained research interviewers
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conversant with quantitative data collection methods.
All participants provided written informed consent for
participating in the bio-behavioral survey and collection of blood samples. The HIV tests used for the study
have been described in detail elsewhere.8 Participants
received INR 40 (approximately 80 USD cents) for
participating in the behavioral survey at each round.

Study measures
Unprotected sex – the primary outcome variable was
defined as self-reported sexual intercourse with no or
inconsistent condom use, i.e. participants did not use
condoms at all sexual encounters. Conversely, protected sex was defined as self-reported sexual intercourse with condom use at all sexual encounters.
Participants who reported to be cohabiting were considered married for this analysis.
To evaluate the effect of the study intervention on
change in sexual behavior, three key project interventions were considered – facility-based HIV counseling
and testing, HIV prevention counseling by ORWs, and
needle syringe services. These interventions were
included as they promote safe behaviors - by providing
free condoms and counseling about their correct and
consistent use to prevent HIV and non-HIV STIs
among PWID and further onward transmission to
their sex partners. Also, studies have shown positive
association between unsafe injecting and unsafe
sexual behavior and hence access to needle syringe
services was selected.14

Data management and statistical analysis
All study related data were stored in passwordprotected computers and were accessible only to the
project team. Analyses were done using STATA version 12.0 (College Station, TX, USA). Descriptive analysis described change in sexual behavior over three time
points. To assess the population-averaged change in
unprotected sex with RFPs from the control phase
(baseline to FV1) to the intervention phase (FV1 to
FV2), a generalized estimating equation (GEE) modeling approach was used. Subsequently, an interaction
term was introduced to assess the impact of uptake of
select interventions on unprotected sex with an RFP.
Final models were adjusted for baseline covariates
including age, education, recruitment method, and
risky injection behavior index at FV2. Logistic regression, using a priori selected variables with potential
effect on sexual behavior, and those which were significantly associated on the bivariate analysis, were used
to determine correlates of unprotected sex with RFPs
at FV2.
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The study was approved by the Technical Resource
Group and Ethics Committee of National AIDS
Control Organization (NACO) in Delhi, the Research
Ethics Committee of PATH, USA and the Institutional
Review Board of the Population Council, USA.

Results
Among 3921 PWID enrolled in the study, 147 were
excluded because of duplicate enrollment or ineligibility
to participate (Figure 1). A total of 1365 male participants reported being married at baseline, and of them
916 (67.1%) returned for data collection at the postintervention FV2. Of those who returned at FV2, 879
(96.0%) had returned for data collection at FV1.
Among participants enrolled in the study, those
who returned for the post-intervention FV2 visit,
were more likely to be less educated (illiteracy 47.4%
versus 43.4%; p ¼ 0.002) and more likely to originate
from Delhi (24.9% versus 17.0%; p ¼ 0.002) compared
to those who did not return for FV2 (Table 1). The two
groups did not differ with respect to age, employment,
HIV-positivity, injection practices, and sexual activity
with women.
Of 916 married men who returned for FV2, more
than a third were aged <30 years (34.1%), and almost
one-half were illiterate (47.4%). Steady means of
income was infrequent as one-half (49.7%) were daily
wage earners. Nearly one-half injected drugs on >15
days a month and a similar proportion reported
risky injecting behaviors in the past one month. HIV
prevalence was high at 18.4%. Self-reported sexual
intercourse with a woman was low, as 43.2% did not
have sex with any woman in the past three months.

Sexual behavior during study follow-up
About half of the married men reported to be sexually
active with any female partner in the past three months
– baseline (55.6%), FV1 (57.7%), and FV2 (52.1%;
Table 2). Anal sex with female partners was reported
by about 7–9% of PWID at each time point. Sex with
male partners in the past three months was reported by
7.1, 2.7, and 6.2% of participants at baseline, FV1, and
FV2, respectively (data not shown).
The proportion of men who reported sexual activity
with an RFP in the past three months decreased over
the study period: 51.5% (baseline), 50.9% (FV1), and
44.0% (FV2) (Table 2).

Change in unprotected sex with an RFP during
intervention phase
Self-reported unprotected sex with an RFP in the past
three months remained high throughout all three study
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Screened for enrollment
N = 3,921
Excluded (n=147)
duplicate enrollment* (n= 139); ineligible for
enrollment (n=8)
Enrolled in study
N=3,774
Excluded from analysis (n=2409)
females (n=26); never married (n=1944);
widowed (n= 137); divorced/separated (n=296);
unknown marital status (n=6)
Included in analysis
N=1,365

Did not return for follow-up visit 1 (n= 486)
reported death (n=42); out-migraon (n=216);
incarceraon (n=35); rehabilitaon (n=13);
refusal (n=25), loss-to-follow up (n=148); other
reasons (n=7)

PWID who returned for preintervenon follow-up visit 1
N= 879
Did not return for follow-up visit 2 (n= 449)
reported death (n=59); out-migraon (n=169);
incarceraon (n=21); rehabilitaon (n=7);
refusal (n=20); loss-to-follow up (n=168); other
reasons (n= 5)

PWID who returned for postintervenon follow-up visit 2
N= 916

Figure 1. Two-year follow-up data of married male participants in the study cohort. *Duplicate enrollment was identified using
personal identifiers such as name, father’s name, and photograph, available on a centralized study database, accessible only to the
project staff. PWID: people who inject drugs.

visits: 46.0% (baseline), 43.5% (FV1), and 37.0% (FV2).
Overall, unprotected sex with an RFP decreased over the
study period – by 2.5% during the control phase (baseline to FV1), and by 6.5% during the intervention
phase (FV1 to FV2). After controlling for age, education, recruitment, and risky injection behavior index, a
13% reduction in odds of unprotected sex with RFPs
was observed during the intervention phase compared
to the control phase, though this was not statistically
significant (GEE adjusted odds ratio (AOR)¼0.87; 95%
confidence interval (95%CI) ¼0.66–1.14; p ¼ 0.310;
data not shown). On further exploration, those who
reported uptake of any select intervention were more
likely to have unprotected sex with an RFP (GEE
AOR ¼ 1.20; 95%CI ¼ 0.87–1.66; p ¼ 0.261) compared
to those who did not access any intervention, and therefore the additional reduction in unprotected sex with
RFPs may not be attributed to the self-reported

uptake of the select study interventions (data
not shown).
However, among men who practiced unprotected
sex with their RFP, a consistent reduction was
observed in the proportion of men who never used
condoms with their RFP: 78.1% (baseline), 68.9%
(FV1), and 62.8% (FV2).

Correlates of unprotected sex at postintervention
follow-up
In multivariable analysis, factors independently associated with unprotected sex at FV2 were living with their
family (AOR ¼ 4.50; 95%CI ¼ 2.72–7.43), awareness of
their most recent HIV test result (AOR ¼ 1.70; 95%
CI ¼ 1.17–2.47), HIV-negative status (AOR ¼ 1.74;
95%CI ¼ 1.14–2.66), and unprotected sex with an
RFP at baseline (AOR ¼ 2.54; 95%CI ¼ 1.83–3.51).
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Table 1. Comparison of sociodemographic and behavioral characteristics of married male PWID who returned and those who did
not return at postintervention follow-up visit 2 (FV2).

Variables

Married men who
returned for
postintervention
follow-up visit 2
(n ¼ 916), n/N (%)

Age
18–29 years
312/916 (34.1%)
30–44 years
406/916 (44.3%)
>45 years
198/916 (21.6%)
Education
Illiterate
434/916 (47.4%)
Class 1–6
255/916 (27.8%)
Class 7 or higher
227/916 (24.8%)
Accommodation
Living in family/relatives’ home
524/916 (57.2%)
Rent/paying guest/care home
181/916 (19.8%)
Living on street/slum/other
211/916 (23.0%)
Employment
Salaried job
98/916 (10.7%)
Daily wage
455/916 (49.7%)
Self-employed
277/916 (30.2%)
Unemployed
86/916 (9.4%)
Place of origin
Delhi
228/916 (24.9%)
Three states adjacent to Delhi
414/916 (45.2%)
Others
274/916 (29.9%)
Duration of injection drug useb
<1 year
325/908 (35.8%)
2–5 years
338/908 (37.2%)
6–10 years
162/908 (17.8%)
>11 years
83/908 (9.2%)
Frequency of injecting drugs in the past one month
Did not inject
90/916 (9.8%)
<15 days/month but at least once
362/916 (39.5%)
>15 days/month
464/916 (50.6%)
Practiced at least one risky injecting behavior in the past one monthb,c
Never
451/898 (50.2%)
At least sometimes
447/898 (49.8%)
HIV status
HIV-negative
703/916 (76.8%)
HIV-positive
169/916 (18.4%)
Unknown HIV status
44/916 (4.8%)
Self-reported sex with a woman in the past three months
Yes
520/916 (56.8%)
No
396/916 (43.2%)
Among those who had sex with a woman in the past three
months, had sex with a regular female partner
Yes
472/520 (90.8%)
No
48/520 (9.2%)

Married men who
did not return for
postintervention
follow-up visit 2
(n ¼ 449), n/N (%)

P-valuea

152/449 (33.8%)
191/449 (42.6%)
106/449 (23.6%)

0.684

195/449 (43.5%)
102/449 (22.7%)
152/449 (33.8%)

0.002

237/449 (52.7%)
111/449 (24.8%)
101/449 (22.5%)

0.097

49/449
223/449
139/449
38/449

(10.9%)
(49.7%)
(31.0%)
(8.4%)

0.951

76/449 (17.0%)
237/449 (52.9%)
136/449 (30.1%)

0.002

166/449
167/449
74/449
42/449

(36.8%)
(37.3%)
(16.5%)
(9.4%)

0.938

47/449 (10.5%)
169/449 (37.6%)
233/449 (51.9%)

0.783

213/439 (48.5%)
226/439 (51.5%)

0.559

337/449 (75.1%)
94/449 (20.9%)
18/449 (4.0%)

0.473

249/449 (55.6%)
200/449 (44.4%)

0.646

232/249 (92.8%)
17/249 (7.2%)

0.346

PWID: people who inject drugs.
a
Pearson’s Chi square test.
b
Subgroups may not add up to totals due to missing data.
c
Risky injection behavior index was the weighted sum of the following practices in the past one month: (i) using used needle or syringe; (ii) back/front
loaded/split drugs; (iii) shared vial, cooker, container, cotton, filter, or water; (iv) received prefilled injection; or (v) drew up drugs from a
common container.
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Table 2. Sexual behavior at three time points among 916 married male PWID who returned for postintervention follow-up visit
2 (FV2).

Variables

Baseline
N ¼ 916 n/N (%)

Preintervention
follow-up visit 1
N ¼ 790 n/N (%)

Sex with any woman in the past three months
Yes
520/916 (55.6%)
456/790 (57.7%)
With regular female partner
472/916 (51.5%)
402/790 (50.9%)
With nonregular female partner
66/916 (7.2%)
66/790 (8.3%)
Sex with regular female partner in the past three months
No sex
444/916 (48.5%)
388/790 (49.1%)
Any unprotected sex
421/916 (46.0%)
344/790 (43.5%)
Protected sex only
51/916 (5.6%)
58/790 (7.4%)
Condom use among those who had unprotected sex with regular female partner in the past three months
Never
329/421 (78.1%)
237/344 (68.9%)
Sometimes
92/421 (21.9%)
107/344 (31.1%)
Condom use at last sex with regular female partner among sexually active mena
No
368/472 (77.9%)
294/402 (73.2%)
Yes
104/472 (22.1%)
108/402 (26.8%)
Sex with nonregular female partner in the past three months
No sex
850/916 (92.8%)
724/790 (91.7%)
Any unprotected sex
29/916 (3.2%)
30/790 (3.8%)
Protected sex only
37/916 (4.0%)
36/790 (4.5%)
Anal sex with any woman in the past three months among sexually active men
No
479/520 (92.1%)
423/456 (92.8%)
Yes
41/520 (7.9%)
33/456 (7.2%)

Postintervention
follow-up visit 2
N ¼ 916 n/N (%)
477/916 (52.1%)
403/916 (44.0%)
97/916 (10.6%)
513/916 (56.0%)
339/916 (37.0%)
64/916 (7.0%)
213/339 (62.8%)
126/339 (37.2%)
285/395 (72.2%)
110/395 (27.8%)
819/916 (89.4%)
63/916 (6.9%)
34/916 (3.7%)
434/477 (90.9%)
43/477 (9.1%)

PWID: people who inject drugs.
a
Subgroups may not add up to totals due to missing data.

Alternatively, risky injection practices in the past month
had a protective effect on unprotected sex compared to
those who reported no risky injection behavior
(AOR ¼ 0.67; 95%CI ¼ 0.47–0.95). Access to select
study interventions was not significantly associated
with unprotected sex with RFPs (see Table 3).

Discussion
To the best of our knowledge, this is the first study in
India to assess change in sexual behavior of men
who inject drugs with their RFP, before and after the
introduction of select HIV prevention interventions.
Additionally, an understanding of the correlates of
unprotected sex among male PWID may provide guidance for designing future interventions to prevent
onward infection transmission to RFPs.
Despite being married, male PWID reported low
sexual activity as only about one-half of them reported
sex with any woman across the study period. Grover
et al.33 reported an adverse effect of drug use on the
endocrine system and higher rates of sexual dysfunction (low sexual desire, inhibited orgasm, painful
sex, and inhibited sexual excitement) with heroin addiction (34–85%), Methadone Maintenance Treatment
(14–81%), or Buprenorphine Maintenance Treatment

(36–83%) compared to the general population.34
Project staff (some of who were former drug users)
also mentioned that PWID are either preoccupied
with arranging for drugs or are under heavy influence
of drugs, both of which makes them unavailable for
sexual intercourse. Poor hygiene due to preoccupation
with drug use further deters them from making any
sexual contact.
Although consistent condom use with RFPs did not
improve over time, an overall reduction in those who
never used condoms with RFPs was observed. It may be
that participants attempted behavior change by using
condoms on certain occasions but could not sustain
this safe behavior. Furthermore, it is possible that
RFPs may have had an increased exposure to healthcare
services, which may have altered certain behaviors and
consequently resulted in a reduction in unprotected sex
during the intervention period. Other reasons, besides
chance, could be the Hawthorne effect, wherein individuals modify an aspect of their behavior in response to
their awareness of being observed. McCambridge et
al.35 reported that answering questions on drinking in
brief intervention trials appeared to alter subsequent
self-reported behavior and found these findings to be
relevant to evaluations of any interventions to change
behaviors which involve participant self-report.
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Table 3. Correlates of self-reported unprotected sex with regular female partners in the past three months among 916 married male
PWID at postintervention follow-up visit 2 (FV2) (n ¼ 916).

Characteristics

Percentage who reported
unprotected sex with regular
female partner in the past
three months % (n/N)

Crude odds ratio
(95%CI)

Age
18–29 years
101/312 (32.4%)
1.00
30–44 years
166/406 (40.9%)
1.44 (1.06–1.96)
>45 years
72/198 (36.4%)
1.19 (0.82–1.73)
Living arrangement
With friends/other drug users
23/161 (14.3%)
1.00
With family
306/628 (48.7%)
5.70 (3.57–9.11)
Alone/others
10/127 (7.9%)
0.51 (0.23–1.12)
Education
Illiterate
152/434 (35.0%)
1.00
Class I–VI
95/255 (37.2%)
1.10 (0.80–1.52)
Class 7 or higher
92/227 (40.5%)
1.26 (0.91–1.76)
Knowledge about HIV/AIDS transmissiona
No comprehensive knowledge
218/598 (36.4%)
1.00
Comprehensive knowledge
121/318 (38.0%)
1.07 (0.81–1.42)
Aware of most recent HIV test result
No
69/231(29.9%)
1.00
Yes
270/685 (39.4%)
1.53 (1.11–2.10)
Perceived HIV risk
No risk
168/367 (45.8%)
1.00
Some risk
156/454 (34.4%)
0.62 (0.47–0.82)
Known HIV-positive
15/95 (15.8%)
0.22 (0.12–0.40)
HIV status
Positive
63/272 (23.2%)
1.00
Negative
255/585 (43.6%)
2.56 (1.85–3.55)
Unknown
21/59 (35.6%)
1.83 (1.00–3.35)
Sex with nonregular female partner in the past three months
Yes
29/97 (29.9%)
1.00
No
310/819 (37.8%)
0.70 (0.44–1.10)
At least one risky injection practice in the past one month
Never
221/508 (43.5%)
1.00
At least sometimes
118/408 (28.9%)
0.53 (0.40–0.70)
Sex with regular female partner in the past three months at baseline
No sex
111/444 (25.0%)
1.00
Unprotected sex
212/421 (50.4%)
3.04 (2.28–4.05)
Protected sex
16/51 (31.4%)
1.37 (0.73–2.57)
Access to comprehensive intervention in the past three months (HCT, HIV prevention counseling
needle syringe program)
No access
102/285 (35.8%)
1.00
Access to only one component
78/239 (32.6%)
0.87 (0.60–1.25)
Access to two components
93/229 (40.6%)
1.23 (0.86–1.75)
Access to all three components
66/163 (40.5%)
1.22 (0.82–1.81)

Adjusted odds
ratio (95%CI)

P-value*

1.00
1.40 (0.98–1.99)
0.98 (0.63–1.51)

0.065
0.922

1.00
4.50 (2.72–7.43)
0.42 (0.19–0.96)

<0.001
0.039

1.00
0.86 (0.59–1.25)
0.80 (0.55–1.18)

0.427
0.269

1.00
0.97 (0.69–1.34)

0.841

1.00
1.70 (1.17–2.47)

0.005

1.00
0.93 (0.67–1.31)
0.39 (0.19–0.82)

0.698
0.013

1.00
1.74 (1.14–2.66)
1.69 (0.81–3.51)

0.010
0.162

1.00
0.86 (0.51–1.45)

0.564

1.00
0.67 (0.47–0.95)

0.023

1.00
2.54 (1.83–3.51)
<0.001
0.99 (0.50–1.96)
0.980
by outreach worker,
1.00
0.78 (0.51–1.19)
1.17 (0.77–1.78)
1.42 (0.87–2.30)

0.252
0.451
0.157

a

HIV knowledge was assessed using a six-item index comprising knowledge that HIV transmission can be prevented by: (i) correct and consistent use of
condoms for sex, (ii) having a monogamous uninfected sexual partner, (iii) sharing of needles/syringes increases the risk of HIV transmission, (iv–v) that
HIV infection cannot spread from mosquito bites or from sharing food, and (vi) healthy looking people can be infected with HIV.
PWID: people who inject drugs.
*P-value for the adjusted multivariable model.

The National IBBS data for India shows high prevalence of unprotected sex among PWID as less than
one-fifth reported consistent condom use with their
RFPs in past 12 months; although it was relatively

higher for Delhi at 23%.22 We report similar findings
as over a third of PWID reported any unprotected sex
with their RFP in the past three months. The GEE
analysis showed a trend towards lower odds of
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unprotected sex with RFPs at the population level
during the intervention phase, though this was not statistically significant. Also, further exploration of the
association showed that uptake of select study interventions was not associated with lower odds of unprotected sex. It is possible that the services were accessed
by participants who intended to practice safe behavior
i.e. consistent condom use but could not execute the
desired behavior change as it may have been more
difficult than anticipated. Further, the extent to which
the actions required for behavior change have been
deliberated also determine the actual change of behavior.36 There are other potential reasons why uptake of
the interventions did not reduce unprotected sex with
RFPs – first, HIV prevention counseling for PWID is
mostly targeted toward encouraging safer injection
practices as it is their most critical HIV risk. Second,
sexual risk behavior counseling often emphasizes
condom use with non-RFPs such as paid sex workers
who have high STI rates (including HIV), and less
often addresses how to stay safe within steady relationships. In India, women involved in steady relationships
with men who inject drugs are mostly monogamous
and noninjecting15,23,37 and thus, present low risk to
their male injecting partners. Further, intention to conceive or use of nonbarrier methods for birth spacing or
birth limiting also discourages condom use, and this is
especially relevant in India, where condom use among
the general population is low (<10%).38
Logistic regression identified important determinants of unprotected sex and may assist to identify
strategies to reduce risk to RFPs. Unprotected sex at
baseline was positively associated with unprotected sex
at the postintervention phase, indicating that the past
condom use behavior can predict future condom use
intentions. Other studies have also reported predictability in intended condom use based on an individual’s
prior history of condom use.39–41 Living with family
was also associated with higher odds of unprotected
sex, as men were likely to be sexually active when
living together with their RFP. Other factors which
increased the odds of unprotected sex with RFPs
included awareness among men about their HIVnegative status. This could be because of no perceived
risk of onward HIV transmission, although it would
put their partners at risk of STIs and unintended pregnancies. This is consistent with findings from other
studies42 and our own baseline study which showed
that safer sexual practices were more common among
HIV-positive study participants than HIV-negative
participants.1 Information about their own HIV
status, which could be a proxy indicator of being
aware of their HIV-negative status, was also associated
with higher odds of unprotected sex. Therefore, it is
essential that PWID undergo repeat HIV counseling
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and testing and comprehend the importance of safer
sexual behaviors, especially if they are HIV-negative.
At least one risky injection practice in the past one
month reduced the odds of unprotected sex with RFPs.
It is possible that men who engage in risky injection
practices were heavy drug users and may have
abstained from having sex with their RFPs; hence the
reduced odds of unprotected sex with them.
Marriages are based on a shared desire for intimacy
and mutual trust. Therefore, introducing condoms into
the relationship is often unwanted and difficult to navigate.43 However, considering the high risk of HIV and
non-HIV STI transmission from men who inject drugs
to their RFPs (with over a third of PWID reporting any
unprotected sex in the past three months), there is an
urgent need to reduce unprotected sex among them. It
is recommended that married male PWID, especially
those who live with their families or are HIVnegative, should receive regular counseling for safe
sex with RFPs with adequate emphasis on dual benefits
of condom use. Couple counseling can be an effective
way to introduce and collectively address potential
challenges in condom use. Use of condoms, irrespective
of other non-barrier contraceptive methods, should be
strongly promoted. Public health programs may also
consider proactive outreach to women with injecting
male partners as they have low perceived risk and inadequate agency to negotiate safe sex.44

Study limitation
There was a sizeable loss-to-follow-up among the study
population – 35.6% at FV1 and 32.9% at FV2, potentially introducing a selection bias. However, married
male PWID who returned at FV2 practiced similar
(baseline) behaviors compared to those who did not
return. Moreover, although the select intervention
was anticipated to reduce unprotected sex, it was not
specifically designed to do so. Also, self-reported
behaviors may be subject to social desirability,
although prior studies have confirmed their validity
among PWID.45 The study recruited close to onefourth of the estimated PWID in Delhi; however, representativeness of the sample cannot be ascertained as
there may be differences in PWID in other districts of
Delhi. Also, we may not have reached PWID who did
not disclose their injection use behavior or were not a
part of drug-using networks.

Conclusion
Our study findings highlight that despite exposure to
key HIV prevention services, unprotected sex with
RFPs continued to be high among married male
PWID. While, focus on reducing drug-use and paid-
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sex related risk behavior is necessary, it is equally
imperative to emphasize on sexual risk reduction
within marriage through couple counseling and direct
outreach to RFPs (wherever possible).
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